Evoke Pharma Receivables 2012-2024 | EVOK

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Evoke Pharma receivables from 2012 to 2024. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Evoke Pharma receivables from 2012 to 2024. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$24.9B
Dr Reddy's Laboratories (RDY)	$12.6B
BridgeBio Pharma (BBIO)	$6.8B
Bausch Health Cos (BHC)	$2.8B
Supernus Pharmaceuticals (SUPN)	$2.1B
Amphastar Pharmaceuticals (AMPH)	$1.7B
Personalis (PSNL)	$396M
Taysha Gene Therapies (TSHA)	$314M
Assembly Biosciences (ASMB)	$95M
Sol-Gel Technologies (SLGL)	$25M
Teligent (TLGT)	$0M